SQSTM1 and Burkitt lymphoma: As a consequence of the CRISPR/Cas9-mediated knockout (KO), Burkitt’s lymphoma (BL) cell lines SavIII and JiJoye without the p62-encoding gene failed to survive (data not shown), making further analysis impossible, although we may find some EBV-transformed lymphoblastic cell lines (LCLs) that can tolerate the removal of the p62-encoding gene.